000 03329nam a22003855i 4500
001 309811
003 MX-SnUAN
005 20160429160325.0
007 cr nn 008mamaa
008 150903s2006 sz | o |||| 0|eng d
020 _a9783764375430
_99783764375430
024 7 _a10.1007/3764375434
_2doi
035 _avtls000362789
039 9 _a201509030649
_bVLOAD
_c201404121602
_dVLOAD
_c201404091340
_dVLOAD
_y201402211058
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
100 1 _aMolineux, Graham.
_eeditor.
_9325140
245 1 0 _aErythropoietins and Erythropoiesis :
_bMolecular, Cellular, Preclinical, and Clinical Biology /
_cedited by Graham Molineux, Mary Ann Foote, Steven G. Elliott.
264 1 _aBasel :
_bBirkhäuser Basel,
_c2006.
300 _ax, 269 páginas
_brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aMilestones in Drug Therapy MDT
500 _aSpringer eBooks
505 0 _aBackground and basic science -- Erythropoiesis: an overview -- Studies of erythropoiesis and the discovery and cloning of recombinant human erythropoietin -- Structural basis for the signal transduction of erythropoietin -- Molecular biology of the erythropoietin receptor in hematopoietic and non-hematopoietic tissues -- Erythropoietin receptor signaling processes -- Clinical pharmacokinetic properties of rHuEPO: a review -- Biology of erythropoietin -- Commercial production of recombinant erythropoietins -- Clinical use of recombinant erythropoietins -- Use of recombinant erythropoietins in the setting of renal disease -- Erythropoietic therapy in the practice of oncology -- Use of recombinant erythropoietins for the treatment of anemia of chronic disease -- Use of erythropoietins in the surgical setting -- Abuse of recombinant erythropoietins by athletes -- Antibodies to endogenous and recombinant erythropoietin -- New molecules and formulations of recombinant human erythropoietin.
520 _aThis volume is a one-source guide to the most current information about red blood cell formation and the action of recombinant human erythropoietins. Topics in the fields of erythropoiesis, recombinant protein discovery and production, and treatment of patients with anemia will be covered. The newest theories in erythropoiesis (receptors, signaling), manufacturing, new formulations, and clinical research are discussed. It is of interest to researchers and clinical investigators in academia and biotechnology and pharmaceutical companies, to clinical research associates, clinical monitors, and physician investigators. This softcover volume is an unchanged second printing of the hardcover edition published in 2003.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700 1 _aFoote, Mary Ann.
_eeditor.
_9319382
700 1 _aElliott, Steven G.
_eeditor.
_9350149
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783764375423
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/3-7643-7543-4
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c309811
_d309811